NCT04715178 Beat Childhood Cancer Specimen Banking and Data Registry
| NCT ID | NCT04715178 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Giselle Sholler |
| Condition | Pediatric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2021-02-02 |
| Primary Completion | 2031-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2021-02-02 with a primary completion date of 2031-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational data registry study of pediatric cancer patients at participating Beat Childhood Cancer Consortium sites involving specimen banking and data collection.
Eligibility Criteria
Inclusion Criteria: * No age restrictions * Subjects that fit into one of the following categories: 1. Subjects with suspected or confirmed cancers of childhood, adolescence, or young adulthood. 2. Survivors of a cancer of childhood, adolescence, or young adulthood (\> 6 months off last therapy for cancer) 3. Subjects with a disease-matched condition 4. Healthy volunteers- including any participants with medical conditions that are not disease-matched. * Written informed consent in accordance with institutional and FDA guidelines must be obtained from all subjects (or subjects' legal representative). Exclusion Criteria: * Subject or his/her legally authorized representative (where applicable) did not consent for specimen banking and data collection for this study.
Contact & Investigator
Giselle Sholler, MD
STUDY CHAIR
Beat Childhood Cancer
Frequently Asked Questions
Who can join the NCT04715178 clinical trial?
This trial is open to participants of all sexes, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04715178 currently recruiting?
Yes, NCT04715178 is actively recruiting participants. Contact the research team at BCCEnroll@pennstatehealth.psu.edu for enrollment information.
Where is the NCT04715178 trial being conducted?
This trial is being conducted at Little Rock, United States, San Diego, United States, Hartford, United States, Miami, United States and 11 additional locations.
Who is sponsoring the NCT04715178 clinical trial?
NCT04715178 is sponsored by Giselle Sholler. The principal investigator is Giselle Sholler, MD at Beat Childhood Cancer. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.